In a May investor call, Globus said it had filed for approval of the robot. The ExcelsiusFlex is designed to provide stereotaxic guidance during orthopedic joint or spine surgeries.
Globus hopes to gain a share of the $15 billion global reconstruction market with the new robot, according to market analysts.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.